ETF Exchange > IBRN ETF
IBRN - ETF Fact Sheet
iShares Neuroscience and Healthcare ETF - USD
Fund Identification
Ticker
IBRN
ISIN
US46436E3532
Main Metrics
Price
$32.81Expense Ratio
0.47%AuM
$6.56MTracking Difference
-0.72%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
The iShares Neuroscience and Healthcare ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
IBRN's historical prices, performance, and flows
1m returns
-1.18%
1m flows
$0M
* Net total returns
All data as of 30 October 2026
The ETF Exchange is brought to you by
With data and analysis by
See all IBRN data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
IBRN's characteristics
Manager
Manager statistics
1824 funds, $6,476.9Bn in AUM
Benchmark
NYSE FactSet Global Neuro Biopharma and MedTech Net Index - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
IBRN's exposure
Countries
USA
66.80%
Other
33.20%
Sectors
Healthcare
98.52%
Top 5 holdings
Biogen, Inc.
4.74%
Edgewise Therapeutics, Inc.
4.36%
PTC Therapeutics, Inc.
4.33%
argenx SE
4.31%
Neurocrine Biosciences, Inc.
4.22%
Total holdings
68
Total weight of top 5
21.96%